Following up on this, the international working group for the prognosis of MDS (IWG-PM) proposed MDS with mutated SF3B1 as a distinct entity if certain criteria are fulfilled (Supplementary Table S1) [11]. Here, SF3B1 is linked to myelodysplastic syndrome.